James Witek
- Epidemiology top 5%
- Hepatology top 1%
- Infectious Diseases top 5%
- Virology top 2%
- Immunology top 10%
- Co-authors
- Peter D. KatsikisJohn D. AltmanYvonne M. MuellerOliver LenzMonika PeetersPaul BojczukBart FeveryMario Roederer
- Topics
- Hepatitis C virus research (30 papers)HIV/AIDS drug development and treatment (30 papers)HIV Research and Treatment (16 papers)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
James Witek
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 68
- Epidemiology 764
- Hepatology 606
- Infectious Diseases 495
- Virology 377
- Immunology 259
Countries citing papers authored by James Witek
This map shows the geographic impact of James Witek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Witek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Witek more than expected).
Fields of papers citing papers by James Witek
This network shows the impact of papers produced by James Witek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Witek. The network helps show where James Witek may publish in the future.
Co-authorship network of co-authors of James Witek
This figure shows the co-authorship network connecting the top 25 collaborators of James Witek. A scholar is included among the top collaborators of James Witek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Witek. James Witek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 28 | |
| 3 | 1 | |
| 4 | Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection. | 4 |
| 5 | Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study | 5 |
| 6 | 82 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 3 | |
| 10 | 22 | |
| 11 | 38 | |
| 12 | 9 | |
| 13 | 16 | |
| 14 | 3 | |
| 15 | 10 | |
| 16 | 16 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 45 | |
| 20 | 137 |
About James Witek
James Witek is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (30 papers), HIV/AIDS drug development and treatment (30 papers) and HIV Research and Treatment (16 papers). The work is most often cited by research in Virology (377 citations), Hepatology (606 citations) and Infectious Diseases (495 citations). James Witek has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Peter D. Katsikis, John D. Altman, Yvonne M. Mueller, Oliver Lenz, Monika Peeters, Paul Bojczuk, Bart Fevery, Mario Roederer, Stephen C. De Rosa and Jane Scott. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.